Table 2 SNPs in the 3′ UTR of KRAS associated with cancer

rs61764370 (KRAS-variant)

Risk of non small-cell lung cancer, epithelial ovarian cancer, triple-negative breast cancer, colorectal cancer. Drug response in metastatic colorectal cancer

[12]-[16],[18],[19]

rs712

Risk of oral squamous cell carcinoma, gastric cancer, colorectal cancer, papillary thyroid cancer

[25]-[28]